Skip to content
Company Analysis

Guardian Pharmacy Services, Inc GRDN

A comprehensive view of key metrics, scores, and financial health for Guardian Pharmacy Services, Inc

Overview of Guardian Pharmacy Services, Inc.

GRDN NYQ
Healthcare Medical Care Facilities Framework: General Corporate Mid Cap
Guardian Pharmacy Services, Inc. (GRDN), is a Mid Cap company, in the Medical Care Facilities industry, last closed at $40.00, about 11.6% undervalued vs fair value, +40.4% 1Y return, ranked 409/1145 in sector.
Metrics P/E 38.7× Rev Growth 17.9% ROE 28.2% Gross Margin 20.2% Div Yield 0.00%
USD 40.00
-1.70%
(Delayed)
• Vol 90d: 43.2%
52-Week Range
Market Cap
$2.53B
Enterprise Value
$2.46B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Fair
Health
Fair
Efficiency
Fair
Valuation
Good
Growth
Fair
Profitability
Fair
Health
Fair
Efficiency
Fair
Valuation
Good
Completeness: 94%
Confidence: 94%
Updated: Oct 31
Top Beats

Quick Facts

Website https://guardianpharmacy.com
HQ Atlanta, GA
Employees 3,400
Fiscal year Dec 31

Next Events

Earnings Nov 5 Call: Nov 5

Fair Value Snapshot

Bear Base Bull
$40
$45
$50
Current: $40.00 +12% vs base

Engine Room Money Flow™

Mid Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$1.4B
17.9%%
Gross Profit
$292.7M
19.8%%
Operating Income
$72.7M
215.5%%
Net Income
$49.2M
156.4%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio FY2025
164.0%
Excellent

Operating Cash Flow / Net Income

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$34.0M
42.1% of FCF

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
2
Active Leaks
0/2
Improving
0
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Guardian Pharmacy Services, Inc's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
58
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • ROIC Sustainably Above Peers ROIC at 90.4th percentile exceeds peers and WACC, demonstrating superior capital allocation.
  • Strong Interest Coverage & Conservative Leverage Debt serviceability is strong (score 0.94), with robust interest coverage.

Key risks

  • Commodity Pressure / Weak Differentiation Gross margin at 31.4th percentile with high volatility suggests weak pricing power or commoditized products.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Developing
44
Premium

Signals, strengths and risks for Pricing Power

Premium

Signals, strengths and risks for Cost Advantage

Premium

Signals, strengths and risks for Customer Stickiness

Premium

Signals, strengths and risks for Capital Efficiency

Premium

Signals, strengths and risks for Resilience

Premium

Signals, strengths and risks for Scale & Market Position

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing GRDN's balance between Growth (37.3%), Profitability (29.6%), and Safety (33.1%). Growth 37% Safety 33% Profitability 30%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

81th percentile vs peers
81
Key Signals
Rev Growth YoY 17.9% 80p Revenue CAGR 3Y 16.8% 82p EPS Growth YoY 1.55 92p EPS CAGR 3Y 10.1% 63p TSR 48.5% 83p
Strengths
  • Growth performance in top 20% of peers (percentile: 81)
  • Rev Growth YoY in top 20% of peers (17.9%, 80th percentile)
  • Revenue CAGR 3Y in top 20% of peers (16.8%, 82th percentile)
  • EPS Growth YoY in top 20% of peers (1.55, 92th percentile)
  • Interest Coverage Ratio in top 20% of peers (111.41, 95th percentile)
Risks

No significant risks identified for this axis.

Profitability

64th percentile vs peers
64
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

72th percentile vs peers
72
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Guardian Pharmacy Services, Inc.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$44.65
- - -
+11.6% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000